Patents by Inventor Rebecca Auer

Rebecca Auer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic rhabdovirus expressing IL12
    Patent number: 11590184
    Abstract: Disclosed herein is an oncolytic recombinant Maraba virus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof. A method for treating a cancer in a patient using the oncolytic recombinant Maraba virus is also disclosed. The present disclosure also provides a tumour cell infected with an oncolytic rhabdovirus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof, for use as an infected cell vaccine (ICV) for the treatment of a cancer. A method for treating a cancer in a patient using the infected cell vaccine is also disclosed.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: February 28, 2023
    Assignee: TURNSTONE LIMITED PARTNERSHIP
    Inventors: Almohanad Alkayyal, Rebecca Auer, John Cameron Bell
  • ONCOLYTIC RHABDOVIRUS EXPRESSING IL12
    Publication number: 20190216868
    Abstract: Disclosed herein is an oncolytic recombinant Maraba virus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof. A method for treating a cancer in a patient using the oncolytic recombinant Maraba virus is also disclosed. The present disclosure also provides a tumour cell infected with an oncolytic rhabdovirus whose genome comprises one or more nucleic acid sequences that, in combination, encode an interleukin-12 (IL12) protein or a functional portion thereof, for use as an infected cell vaccine (ICV) for the treatment of a cancer. A method for treating a cancer in a patient using the infected cell vaccine is also disclosed.
    Type: Application
    Filed: August 9, 2017
    Publication date: July 18, 2019
    Inventors: Almohanad Alkayyal, Rebecca Auer, John Cameron Bell